Mavoglurant
Mavoglurant (AFQ056) is a potent, selective, non-competitive and orally active mGluR5 antagonist, with an IC50 of 30 nM. Mavoglurant shows a >300 fold selectivity for the mGluR5 over all targets (238) tested. Mavoglurant can be used for the research of Fragile X syndrome (FXS), and L-dopa induced dyskinesias in Parkinson's disease[1][1][2]. Mavoglurant is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Product Specifications
CAS Number
543906-09-8
Product Name Alternative
AFQ056
UNSPSC
12352005
Hazard Statement
H302
Target
MGluR
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/Mavoglurant.html
Purity
99.88
Solubility
DMSO : 120 mg/mL (ultrasonic)
Smiles
CC1=CC(C#C[C@]2(O)CCC[C@]3([H])[C@@]2([H])CCN3C(OC)=O)=CC=C1
Molecular Formula
C19H23NO3
Molecular Weight
313.39
Precautions
H302
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 3
Isoform
MGluR5
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
MiTF (Microphthalmia Transcription Factor) (MITF/915), CF594 conjugate, 0.1mg/mL
Human Lambda Light Chain (B-Cell Marker) (rLLC/3777), CF647 conjugate, 0.1mg/mL
